Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: My view from here ... Deeper Analysis ...
9
Oct 19, 2013 09:54AM
22
Oct 19, 2013 01:16PM
4
Oct 19, 2013 04:05PM
1
Oct 19, 2013 04:33PM
2
Oct 19, 2013 04:44PM
1
Oct 19, 2013 05:01PM
5
Oct 19, 2013 05:08PM
11
Oct 19, 2013 05:53PM
2
Oct 19, 2013 07:22PM
2
Oct 19, 2013 11:18PM
3
Oct 20, 2013 03:19AM
10
Oct 20, 2013 11:17AM
6
Oct 20, 2013 01:33PM
5
Oct 20, 2013 02:51PM
4
Oct 20, 2013 03:00PM
10
Oct 20, 2013 05:00PM
4
Oct 20, 2013 05:08PM
3
Oct 20, 2013 05:20PM
16
Oct 20, 2013 05:30PM
4
Oct 20, 2013 05:52PM
13
Oct 20, 2013 05:53PM

Oct 20, 2013 05:56PM
2
Oct 20, 2013 06:20PM
1
Oct 20, 2013 06:21PM
1
Oct 20, 2013 06:37PM
1
Oct 20, 2013 06:42PM
4
Oct 20, 2013 06:56PM
7
Oct 20, 2013 07:03PM
2
Oct 20, 2013 07:22PM
4
Oct 20, 2013 07:28PM
"If you think the MMP will apply a royalty rate against another 1.4 trillion in revenue from the remaining infringers for the next couple years, multiply that by the NDoC award rate of .000125 you get 175 million probably divided by 3 for the Leckrone Family and Moore, Ottesson, and PTSC. That equals 55 million for PTSC for the remainder of the MMP life". <<<<>>>> I think the above should be considered to determine if PTSC should act. The Leckrone family equals say 5 to 15 million divided to probably 5 to 10 people. 15 to 20 million to Moore. 30 million to Ottesson to his company to fu d 50 people. 55 million to PTSC divided by 16,000 shareholders. The dollar amounts are directional only to prove a point and are not meant to be exact. Every single group related to the MMP revenue benefits significantly with the exception of PTSC. Is that a reason to not allow the Leckrone family to win? I say yes ...
5
Oct 20, 2013 08:23PM
2
Oct 20, 2013 08:25PM
2
Oct 20, 2013 08:34PM
4
Oct 20, 2013 10:10PM
2
Oct 21, 2013 08:38AM

Oct 21, 2013 08:46AM
5
Oct 21, 2013 09:27AM
Share
New Message
Please login to post a reply